US equities |
MU $935.60 ▼-5.40% META $763.51 ▲+2.77% NVDA $226.99 ▲+0.30% SNDK $1,445.96 ▼-2.78% MSFT $545.94 ▲+0.89% AAPL $342.68 ▲+0.50% SPCX $156.89 ▼-4.00% AMD $595.80 ▲+0.26%
FinancialContent

Heartflow, Inc. - Common Stock (NQ:HTFL)

50.60 +0.04 (+0.08%)
Delayed Quote Updated: 2:47 PM EDT, Oct 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Heartflow, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High ↗
The provider of an artificial intelligence-powered cardiac diagnostic platform reported a notable insider stock sale. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High ↗
The medical technology company reported a notable insider sale as its shares delivered a 59% one-year return. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty,... 
From Heartflow, Inc.
Via GlobeNewswire
Heartflow Inc (NASDAQ:HTFL) Beats Q1 Estimates and Hikes Full-Year Outlook, But Stock Slips After Hours ↗
Via Chartmill
News headline image
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference
From Heartflow, Inc.
Via GlobeNewswire
News headline image
HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors? ↗
The medical technology company reported a notable insider sale as shares returned 35% over the past year. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why Heartflow Stock Soared Today ↗
The healthcare technology leader is using artificial intelligence to detect coronary artery disease early. 
Via The Motley Fool
Topics Artificial Intelligence
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Friday's session: gap up and gap down stocks ↗
Via Chartmill
Discover the top movers in Friday's pre-market session. ↗
Via Chartmill
News headline image
Heartflow Q2 Earnings Call Highlights ↗
Heartflow (NASDAQ:HTFL) reported second-quarter revenue of $64.1 million, up 48% from a year earlier, as growth in its Plaque Analysis offering, durable FFR-CT utilization and continued expansion of... 
Via MarketBeat
Topics Earnings
News headline image
HeartFlow Q2 2026 Earnings Call Transcript ↗
HeartFlow (NASDAQ:HTFL) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For... 
Via Benzinga
Topics Earnings
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026
From Heartflow, Inc.
Via GlobeNewswire
News headline image
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors? ↗
The medical technology company reported a notable insider sale in recent filings. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026? ↗
Heartflow boasts rapid AI-driven growth but faces reimbursement headwinds, while Omeros bets everything on its first commercial launch. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026? ↗
Heartflow scales AI diagnostics while Iovance drives personalized cancer therapies, each faces unique financial and operational risks in 2026. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026? ↗
AI-powered diagnostics meet global oncology innovation as two medical disruptors post strong revenue growth, yet face distinct risk and valuation profiles. 
Via The Motley Fool
Topics Artificial Intelligence
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million? ↗
HeartFlow delivers AI-powered, non-invasive cardiac diagnostics for hospitals and cardiology clinics using proprietary imaging technology. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Heartflow Q1 Earnings Call Highlights ↗
Heartflow (NASDAQ:HTFL) reported a sharply higher first-quarter revenue total and raised its full-year 2026 outlook, citing strength in its core FFRCT business, faster-than-expected adoption of its... 
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
From Heartflow, Inc.
Via GlobeNewswire
News headline image
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
Wall Street Waits for the SpaceX IPO, These 2 Under-the-Radar IPOs Could Already Be Making You Money ↗
Heartflow and Neptune Insurance deserve a closer look. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Advances AI Voice-Based Intoxication Detection as Real-Time Diagnostics Market Expands
Via Investor Brand Network
Topics Artificial Intelligence
The Future of Intoxication Detection May Be in Your Voice
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors. ↗
HeartFlow provides AI-driven tools for non-invasive heart diagnostics, serving hospitals and clinics with advanced cardiovascular insights. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
The Future of Intoxication Detection May Be in Your Voice
From BioMedWire
Via GlobeNewswire
< Previous 1 2 3 Next >